• Najah Al-muhtaseb
  • Elham Al-kaissi Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Petra, Amman, Jordan
  • Zuhair Muhi-eldeen
  • Tawfeeq Arafat
  • Sabah Al-muhtaseb
  • Hani Atiyah


Acute myocardial infarction, xanthine Oxidase, Malondialdehyde, antioxidants, Lipid profile


Objective: This study aim to investigate the levels of oxidative stress, antioxidants besides uric acid, C-reactive protein (CRP), lipid profile and cardiac biomarker enzymes in young men admitted to the hospital for the first time with acute myocardial infarction (AMI), to investigate any Relationship between them.

Methods: 135 young men age Ë‚ 40 y old, admitted to the cardiology unit with suspected MI and 130 age and sex matched healthy controls were included in this study. Blood samples were collected from the patients and the control group. The blood samples were collected from the patients on the day of admission and on the day of discharge.

Results: The levels of xanthine oxidase (XO), malondialdehyde (MDA), CRP, uric acid, total cholesterol (TC), total triglyceride (TG), low-density lipoprotein (LDL-C), apoprotein-B 100 (Apo B), and cardiac biomarker enzymes were significantly high, whereas catalase, vitamin C, high-density lipoprotein (HDL-C) and apoprotein-A1 (Apo A1) were significantly low on the day of admission (Time A) and slightly higher on the day of discharge (Time B), but both were still lower than the controls. There was a decrease in XO and MDA activity and an increase in catalase activity and vitamin C level.

Conclusion: These results may indicate possible relationships between these parameters and AMI.

Keywords: Acute myocardial infarction, Xanthine oxidase, Malondialdehyde, Antioxidants, Lipid profile


Download data is not yet available.


Fuster V, Badimon L, Badimon J, Chesebro JH. Mechanisms of disease: the pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.

Thakur SK, Jaggi K, Rathore B, Chander R, Mahdi F, Mathur A. Assessment of oxidative stress, antioxidant enzymes and lipid profile in the subjects of coronary artery disease (CAD). Int J Pharma Sci Res 2014;5:3042-6.

Lamm G. The epidemiology of acute myocardial infarction in young age groups in myocardial infarction at a young age. Springer-Verlag, Heidelberg 1981;13:5-7.

Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart study. N Engl J Med 1998;338:1650-6.

Chesebro JH, Rauch U, Fuster V, Badimon JJ. Pathogenesis of thrombosis in coronary artery disease. Haemostasis 1997;2:12-8.

Ahmad MI, Sharma N. Biomarkers in acute myocardial infarction. J Clin Exp Cardiol 2012;3:11:1-8.

Pandey R, Gupta NK, Wander GS. Diagnosis of acute myocardial infarction. Supplement to JAPI 2011;59:8-13.

Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in human. Circulation 1999;100:1161-8.

Griever DJ, Shah AM. Oxidative stress in heart failure: more than just damage. Eur Heart J 2003;24:2161-3.

Braunwald E. biomarkers in heart failure. N Engl J Med 2008;358:20.

Pandey NR, Kaur G, Chandra M, Sanwal GG, Misra MK. Enzymatic oxidant and antioxidants of human blood platelets in unstable angina and myocardial infarction. Int J Cardiol 2000;76:33-8.

Xia Y, Khatchikian G, Zweier J. Adenosine deaminase inhibition prevents free radical mediated injury in the post-ischemic. J Biol Chem 1996;271:10096-102.

Gorman SLT, Zweier JL. Evaluation of the role of xanthine oxidase in myocardial reperfusion injury. J Biol Chem 1990;265:6656-63.

Hille R. Structure and function of Xanthine oxidoreductase. Eur J Inorg Chem 2006;10:1905-2095.

Raghuvanshi R, Chandra M, Misra PC, Misra MK. Effect of vitamin E on the platelet Xanthine oxidase and lipid peroxidation in the patients of myocardial infarction. Indian J Clin Biochem 2005;20:26-9.

Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol 2004;555:589-606.

Kittleson MM, John ME, Bead V, Champion HC, Kasper EK, Russell SD. Increased levels of uric acid predict hemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels. Heart 2007;93:365-7.

Baruah M, Nath CK, Chaudhury B, Devi R, Ivvala AS. A study of serum uric acid and C-reactive protein in acute myocardial infarction. Int J Basic Med Sci Pharm 2012;2:21-4.

Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol 2002;89:145-9.

Lakic D, Bogavac-Stanojevic N, Jelic-Ivanovic Z, Kotur-Stevuljevic J, Spasic S, Kos M. A multimarker approach for the prediction of coronary artery disease: Cost-effectiveness analysis. Int Soc For Pharmacoeconomics Outcomes Res 2010;13:770-7.

Kotur–Stevuljevic J, Memon L, Stefanovic A, Spasic S, Kalimanouska VS, Bogavac-Stanojevic N, et al. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin Biochem 2007;40:181-7.

Soydinc S, Celik A, Demiryurek S. The relationship between oxidative stress, nitric oxide, and coronary artery disease. Eur J Gen Med 2007:4;62-6.

Kastelein J, Wedel MK, Baker BF, Su J, Bradly JD, Yu RZ, et al. Potent reduction of apolipoprotein B and low-density lipoprotein cholesterol by short-term administration of an antisense inhibitor of apolipoprotein B. Circulation 2006;114:1729-35.

Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E. High apolipoprotein B, low apolipoprotein A1, and improvement in the prediction of fatal myocardial infarction (AMORIS study) a prospective study. Lancet 2001;358:2026-33.

Haidari M, Moghadam M, Chinicar M, Ahmadieh A, Doosti M. Apolipoprotein B as the best predictor of coronary artery disease in Iranian normolipidemic patients. Clin Biochem 2001;34:149-55.

Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41:1819-27.

Shilpa HD, Anita RB. Malondialdehyde as a marker of lipid peroxidation in acute myocardial infarction patients. MRIMS J Health Sci 2013;1:20-2.

Kumar SV, Saritha G, Fareedullah Md. The role of antioxidants and oxidative stress in cardiovascular disease. Ann Biol Res 2010;1:158-73.

Khaki-Khatibi F, Yaghoubi AR, Rahbani NM. Study of antioxidant enzymes lipid peroxidation, lipid profile and immunologic factor in coronary artery disease in east Azarbijan. Int J Med Biomed Res 2012;1:147-51.

Pham-Huy AL, Hc H, Pham–Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci 2008;4:89-96.

Koepke JL, Wood CS, Terlecky LJ, Waltson PA, Terlecky SR. Progeric effects of catalase inactivation in human cells. Toxicol Appl Pharmacol 2008,232:99-108.

Allain CC, Poon IS, Chan CHG, Richmond W. Enzymatic determination of serum total cholesterol. Clin Chem 1974;20:470-1.

Jacobs NJ, Van Denmark PJ. Enzymatic determination of serum triglycerides. Biochem Biophys 1960:88:250-5.

Gordon T, Gordon M. An enzymatic method for the determination of the serum HDL-cholesterol. Am J Med 1977;62:707-8.

Fridewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL–cholesterol. Clin Chem 1972;18:499-515.

Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969;6:24-6.

Balis ME. Uric acid metabolism in man. Adv Clin Chem 1976;18:213-46.

Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-10.

Nishino T. The conversion of xanthine oxidase dehydrogenase to xanthine oxidase and the role of the enzyme in perfusion injury. J Biochem 1994;16:1-6.

Roe HJ, Kuether CA. Detection of ascorbic acid in whole blood and urine through the 2,4-dinitrophenyl-hydeazine derivative of dehydroascorbic acid. J Biol Chem 1943;147:399-407.

Goth LA. A simple method for determination of serum catalase activity and revision of reference range. Clin Chem Acta 1991;196:143-52.

Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003;169:203-14.

Yilmaz A, Yalta K, Turgut OO, Yilmaz MB, Ozyol A, Kendirlioglu O, et al. Clinical importance of elevated CK-MB and troponin I level in congestive heart failure. Adv Ther 2006;23:1060-7.

Khan HA, ALhomida AS, Sobki SH, Sobki SH, Habib SS, Al Aseri Z, et al. Serum markers of tissue damage and oxidative stress in patients with acute myocardial infarction. Biomed Res 2013;24:15-20.

Nikfardjam M, Mullner M, Schreiber W, Oschatz E, Exner M, Domanovits H, et al. The association between a C-reactive protein on admission and mortality in patients with acute myocardial infarction. J Intern Med 2000;247:341-5.

Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death? Lancet 1999;359:1578.

Tatli E, Aktoz M, Buyuklu M, Altun A. The relationship between coronary artery disease and uric acid levels in young patients with acute myocardial infarction. Cardiol J 2008;15:21-5.

Katib FK, Samadi N, Ghojazade M, Yaghoubi A. Association between inflammatory factor, lipid peroxidation and total antioxidant in non-diabetic patients of coronary artery disease. J Anal Res Clin Med 2014;2:30-5.

Meisinger C, Loewel H, Marza W, Koenig W. Prognostic value of apolipoprotein B and AI in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study. Eur Heart J 2005;26:271-8.

Hamzah MO, Hussein AG, Turki KM. Study of some cardiac biomarkers and oxidative stress markers in patients with acute coronary syndromes. Karbala J Med 2011;4:1102-8.

Kharb S, Singh GP. Effect of smoking on lipid profile, lipid peroxidation and antioxidant status in normal subjects and in patients during and after acute myocardial infarction. Clin Chim Acta 2000;302:213-9.

Pasupathi P, Rao YY, farook J, Saravanan G, Bakthathsalam G. Oxidative stress and cardiac biomarkers in patients with acute myocardial infarction. Am-Eurasian J Sci Res 2009;27:275-85.

Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007;39:44-84.

Ng LL. Targeting oxidative stress in heart failure. Heart Meta 2009;42:21-4.

Aksoy S, Cam N, Gurkan U, Dilaver OZ, Ozden K, Altay S, et al. Oxidative stress and severity of coronary artery disease in young smokers with acute myocardial infarction. Cardiol J 2012;19:38-6.

Raghuvanshi R, Kaul A, Bhakuni P, Mishra A, Misra MK. Xanthine oxidase as a marker of myocardial infarction. Indian J Clin Biochem 2007;22:90-2.

Patil N, Chavan V, Karnik ND. Antioxidant status in patients with acute myocardial infarction. Indian J Clin Biochem 2007;22:45-5.



How to Cite

Al-muhtaseb, N., E. Al-kaissi, Z. Muhi-eldeen, T. Arafat, S. Al-muhtaseb, and H. Atiyah. “OXIDANTS AND ANTIOXIDANTS AS RISK FACTORS IN YOUNG ARABIAN MALE PATIENTS WITH ACUTE MYOCARDIAL INFARCTION”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 6, June 2016, pp. 273-7, https://innovareacademics.in/journals/index.php/ijpps/article/view/11845.



Original Article(s)

Most read articles by the same author(s)